Literature DB >> 22469561

Erythrocytes load of low molecular weight chitosan nanoparticles as a potential vascular drug delivery system.

Wen Fan1, Wei Yan, Zushun Xu, Hong Ni.   

Abstract

Low molecular weight (LMW) chitosan nanoparticles have attracted considerable attention as colloidal drug carriers, but when applied to intravascular drug delivery, they are easy to be removed from circulation by the reticuloendothelial system, which limits their applications as long-circulating or target-specific carriers. Erythrocytes have a long circulation time in the blood, but they are sometimes not suitable for loading and releasing of drug directly. The combination of LMW chitosan nanoparticles and erythrocytes that complement each other is a desirable strategy to develop a multifunctional drug carrier. In this study, monodisperse, LMW chitosan nanoparticles were prepared by ionic gelation technique and these nanoparticles were investigated with regard to their erythrocyte compatibility. Then the interactions between erythrocytes and fluorescence-labeled LMW chitosan nanoparticles were studied by confocal microscopy. The results of this study indicate that LMW chitosan nanoparticles show good compatibility with erythrocytes and they can be easily attached to the surface of erythrocyte membrane, suggesting that erythrocytes load of LMW chitosan nanoparticles can be served as a potential vascular drug delivery system.
Copyright © 2012 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22469561     DOI: 10.1016/j.colsurfb.2012.03.006

Source DB:  PubMed          Journal:  Colloids Surf B Biointerfaces        ISSN: 0927-7765            Impact factor:   5.268


  10 in total

1.  Blood viscosity as a sensitive indicator for paclitaxel induced oxidative stress in human whole blood.

Authors:  Gamaleldin I Harisa
Journal:  Saudi Pharm J       Date:  2014-04-30       Impact factor: 4.330

2.  Simulation of the osmosis-based drug encapsulation in erythrocytes.

Authors:  Duobiao Ge; Lili Zou; Chengpan Li; Sen Liu; Shibo Li; Sijie Sun; Weiping Ding
Journal:  Eur Biophys J       Date:  2017-09-20       Impact factor: 1.733

3.  Evidence Supporting the Safety of Pegylated Diethylaminoethyl-Chitosan Polymer as a Nanovector for Gene Therapy Applications.

Authors:  Elsa Patricia Rondon; Houda Abir Benabdoun; Francis Vallières; Maicon Segalla Petrônio; Marcio José Tiera; Mohamed Benderdour; Julio Cesar Fernandes
Journal:  Int J Nanomedicine       Date:  2020-08-20

Review 4.  PLGA's Plight and the Role of Stealth Surface Modification Strategies in Its Use for Intravenous Particulate Drug Delivery.

Authors:  Violet V Sheffey; Emily B Siew; Eden E L Tanner; Omolola Eniola-Adefeso
Journal:  Adv Healthc Mater       Date:  2022-01-27       Impact factor: 11.092

Review 5.  A Review on Chitosan's Uses as Biomaterial: Tissue Engineering, Drug Delivery Systems and Cancer Treatment.

Authors:  Rayssa de Sousa Victor; Adillys Marcelo da Cunha Santos; Bianca Viana de Sousa; Gelmires de Araújo Neves; Lisiane Navarro de Lima Santana; Romualdo Rodrigues Menezes
Journal:  Materials (Basel)       Date:  2020-11-06       Impact factor: 3.623

6.  Evaluation of hemagglutination activity of chitosan nanoparticles using human erythrocytes.

Authors:  Jefferson Muniz de Lima; Ronaldo Rodrigues Sarmento; Joelma Rodrigues de Souza; Fábio André Brayner; Ana Paula Sampaio Feitosa; Rafael Padilha; Luiz Carlos Alves; Isaque Jerônimo Porto; Roberta Ferreti Bonan Dantas Batista; Juliano Elvis de Oliveira; Eliton Souto de Medeiros; Paulo Rogério Ferreti Bonan; Lúcio Roberto Castellano
Journal:  Biomed Res Int       Date:  2015-02-11       Impact factor: 3.411

7.  Pravastatin chitosan nanogels-loaded erythrocytes as a new delivery strategy for targeting liver cancer.

Authors:  Gamaleldin I Harisa; Mohamed M Badran; Saeed A AlQahtani; Fars K Alanazi; Sabry M Attia
Journal:  Saudi Pharm J       Date:  2015-03-21       Impact factor: 4.330

8.  Chitosan treatment abrogates hypercholesterolemia-induced erythrocyte's arginase activation.

Authors:  Gamaleldin I Harisa; Sabry M Attia; Khairy M A Zoheir; Fars K Alanazi
Journal:  Saudi Pharm J       Date:  2016-05-26       Impact factor: 4.330

9.  Cytotoxicity Enhancement in MCF-7 Breast Cancer Cells with Depolymerized Chitosan Delivery of α-Mangostin.

Authors:  Yedi Herdiana; Nasrul Wathoni; Shaharum Shamsuddin; Muchtaridi Muchtaridi
Journal:  Polymers (Basel)       Date:  2022-08-01       Impact factor: 4.967

10.  The discovery of berberine erythrocyte-hemoglobin self-assembly delivery system: a neglected carrier underlying its pharmacokinetics.

Authors:  Qiuxia Yu; Minhua Li; Hanbin Chen; Lieqiang Xu; Juanjuan Cheng; Guoshu Lin; Yuhong Liu; Ziren Su; Xiaobo Yang; Yucui Li; Jiannan Chen; Jianhui Xie
Journal:  Drug Deliv       Date:  2022-12       Impact factor: 6.419

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.